Skip to main content

Remote Job Finders (RJF)

Pascal Soriot’s comments came during AstraZeneca’s Q2 earnings call in regard to President Donald Trump’s newly announced European pharma tariffs. The company also announced estimate-beating earnings, with its cancer portfolio driving earnings despite clinical roadblocks.
AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D
Scroll to top